How Much Longer Will This Company Be Around?

[AnonymousJohnDough]

How do you sell a product with 8 reps to cover NA? Oh that's right you don't

 

[Anonymous]

Ok
Here's the scoop
No BS here

They are down to 2 suitors for IDEV
BSX and ABT

No clue why either one of these companies would waste their money on this POS
It's one thing if they bought it fir super cheap but I'm hearing some big dollars

Another colossal screw up is going to be made by one of these companies

 

[Anonymous]

BSX actually makes sense as a potential suitor. The have an excellent presence in the Biliary stenting market. The Wallstent is still used there and very similar, IDEV never made a push to get into this market space (interesting enough, considering it's indicated for Biliary). But it's a great chance to bolster that portion of their product pipeline, and if they happen to make 30-40 million/yr selling this stent in endovascular use, great for them. But what about Covidien, they do have a position in the company and it's a space they want to be in?

 

[Anonymous]

Abbott buy-out $310 million...

 

[Anonymous]

Anyone know the price per share?

 

[Anonymous]

Game over.

 

[Anonymous]

Ha ha you morons. Abbot did buy the company (although I will agree the stent is a pos). Hope all you anonymous posters work for Abbot. Not it's in your bag idiots!